Global Alzheimer’s Disease Drug Market Research Report 2015-2025
- HEY3760541
- 82 Pages
- March 2020
- Healthcare
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer’s Disease Drug market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Donepezil
Memantine
Rivastigmine
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Lundbeck.
Merz Pharma
Eisai
Daiichi Sankyo
Johnson & Johnson
Novartis
Allergan
Pfizer
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Early to Moderate Stages
Moderate to Severe Stages
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Alzheimer’s Disease Drug Picture
1.1.2 Specifications
Table Product Specifications of Alzheimer’s Disease Drug
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Alzheimer’s Disease Drug
Table Global Alzheimer’s Disease Drug Market by Type, 2011-2022 (USD Million)
1.2.1.1 Donepezil
Table Donepezil Overview
1.2.1.2 Memantine
Table Memantine Overview
1.2.1.3 Rivastigmine
Table Rivastigmine Overview
1.2.2 by Application
Table Application Segment of Alzheimer’s Disease Drug
Table Global Alzheimer’s Disease Drug Market by Application, 2011-2022 (USD Million)
1.2.2.1 Early to Moderate Stages
Table Early to Moderate Stages Overview
1.2.2.2 Moderate to Severe Stages
Table Moderate to Severe Stages Overview
1.2.3 by Regions
Table Global Alzheimer’s Disease Drug Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Alzheimer’s Disease Drug
2.2 Upstream
Table Cost of Alzheimer’s Disease Drug
Figure Manufacturing Process of Alzheimer’s Disease Drug
2.3 Market
2.3.1 SWOT
Figure SWOT of Alzheimer’s Disease Drug
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Alzheimer’s Disease Drug
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Alzheimer’s Disease Drug
3.4 Market Entry
Table Market Entry of Alzheimer’s Disease Drug
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Donepezil Market, 2013-2018
Figure Donepezil Market Size and Growth, 2015-2019 (USD Million)
Figure Donepezil Market Size and Growth, 2015-2019 (in Volume)
Table Donepezil CAGR by Revenue and Volume, 2015-2019
4.1.2 Memantine Market, 2013-2018
Figure Memantine Market Size and Growth, 2015-2019 (USD Million)
Figure Memantine Market Size and Growth, 2015-2019 (in Volume)
Table Memantine CAGR by Revenue and Volume, 2015-2019
4.1.3 Rivastigmine Market, 2013-2018
Figure Rivastigmine Market Size and Growth, 2015-2019 (USD Million)
Figure Rivastigmine Market Size and Growth, 2015-2019 (in Volume)
Table Rivastigmine CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Donepezil Market Forecast, 2020-2025
Figure Donepezil Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Donepezil Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Donepezil CAGR by Revenue and Volume, 2012-2024
4.2.2 Memantine Market Forecast, 2020-2025
Figure Memantine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Memantine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Memantine CAGR by Revenue and Volume, 2012-2024
4.2.3 Rivastigmine Market Forecast, 2020-2025
Figure Rivastigmine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Rivastigmine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Rivastigmine CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Early to Moderate Stages Market, 2013-2018
Figure Early to Moderate Stages Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Early to Moderate Stages CAGR by Revenue and Volume, 2015-2019
5.1.2 Moderate to Severe Stages Market, 2013-2018
Figure Moderate to Severe Stages Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Moderate to Severe Stages CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Early to Moderate Stages Market Forecast, 2020-2025
Figure Early to Moderate Stages Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Early to Moderate Stages Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Early to Moderate Stages CAGR by Revenue and Volume, 2020-2025
5.2.2 Moderate to Severe Stages Market Forecast, 2020-2025
Figure Moderate to Severe Stages Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Moderate to Severe Stages Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Moderate to Severe Stages CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Alzheimer’s Disease Drug Market by Vendors, 2015-2019 (in Volume)
Table Global Alzheimer’s Disease Drug Market Share by Vendors, 2015-2019 (USD Million)
Table Global Alzheimer’s Disease Drug Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Alzheimer’s Disease Drug Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Lundbeck.
Table Lundbeck. Profile List
Table Microecological Modulator Operating Data of Lundbeck. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Merz Pharma
Table Merz Pharma Profile List
Table Microecological Modulator Operating Data of Merz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Eisai
Table Eisai Profile List
Table Microecological Modulator Operating Data of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Daiichi Sankyo
Table Daiichi Sankyo Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Johnson & Johnson
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Allergan
Table Allergan Profile List
Table Microecological Modulator Operating Data of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Alzheimer’s Disease Drug
Table Products Segment of Alzheimer’s Disease Drug
Table Global Alzheimer’s Disease Drug Market by Type, 2011-2022 (USD Million)
Table Donepezil Overview
Table Memantine Overview
Table Rivastigmine Overview
Table Application Segment of Alzheimer’s Disease Drug
Table Global Alzheimer’s Disease Drug Market by Application, 2011-2022 (USD Million)
Table Early to Moderate Stages Overview
Table Moderate to Severe Stages Overview
Table Global Alzheimer’s Disease Drug Market by Region, 2011-2022 (USD Million)
Table Cost of Alzheimer’s Disease Drug
Table Market Dynamics
Table Policy of Alzheimer’s Disease Drug
Table GDP of Major Countries
Table Technology of Alzheimer’s Disease Drug
Table Market Entry of Alzheimer’s Disease Drug
Table Donepezil CAGR by Revenue and Volume, 2015-2019
Table Memantine CAGR by Revenue and Volume, 2015-2019
Table Rivastigmine CAGR by Revenue and Volume, 2015-2019
Table Donepezil CAGR by Revenue and Volume, 2012-2024
Table Memantine CAGR by Revenue and Volume, 2012-2024
Table Rivastigmine CAGR by Revenue and Volume, 2012-2024
Table Early to Moderate Stages CAGR by Revenue and Volume, 2015-2019
Table Moderate to Severe Stages CAGR by Revenue and Volume, 2015-2019
Table Early to Moderate Stages CAGR by Revenue and Volume, 2020-2025
Table Moderate to Severe Stages CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Alzheimer’s Disease Drug Market by Vendors, 2015-2019 (in Volume)
Table Global Alzheimer’s Disease Drug Market Share by Vendors, 2015-2019 (USD Million)
Table Global Alzheimer’s Disease Drug Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Lundbeck. Profile List
Table Microecological Modulator Operating Data of Lundbeck. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merz Pharma Profile List
Table Microecological Modulator Operating Data of Merz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Profile List
Table Microecological Modulator Operating Data of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Profile List
Table Microecological Modulator Operating Data of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
